PT-112 monotherapy advances to phase 3 trial in metastatic castration-resistant prostate cancer after positive FDA end of ...

the thymus tissue naturally regenerates. However, regrowth is slow, and restoration of young T-cells takes a long time, leaving individuals more susceptible to infections and tumor recurrence.

During a recent appearance on "The Kelly Clarkson Show," the 57-year-old actress recalled being diagnosed with a noncancerous brain tumor in 2015 and shared how the experience changed her approach ...

These can be the result of a thymus tumor pressing on nearby blood vessels, airways, or the esophagus. Sometimes persons with thymomas can develop other immune conditions. These include: Surgically ...

It discusses the different types of mediastinal tumors, including thymomas, thymic neuroendocrine tumors, germ cell tumors, and neurogenic tumors. The article highlights the etiology, risk factors ...

Thymoma and thymic carcinoma are rare cancers known as thymic epithelial tumors. Thymoma cancer cells grow slowly and rarely spread beyond the thymus, while thymic carcinoma grows more quickly and ...

The National Cancer Institute today presented preliminary results from the Phase 2 clinical trial of Promontory’s lead therapeutic candidate, PT-112, in patients with recurrent thymic epithelial ...

ABSTRACT: Background: Thymic tumors are rare entity with little information regarding outcomes after therapy with curative intent. They are heterogeneous group of neoplastic lesions with wide spectrum ...

It may also provide insight into your outlook. Thymomas are cancerous tumors that grow in your thymus — a gland in your chest that helps make immune system cells. Thymomas and thymic carcinomas ...

TRAIL tumor necrosis factor–related apoptosis-inducing ligand, TSLP thymic stromal lymphopoietin, and VEGF vascular endothelial growth factor. T-cell clonality (i.e., the degree of sameness of ...